Respiratory Syncytial Virus in Older Adults: Setting the Foundation

New reports from ECCMID 2022 shed light on the disease burden of RSV in older adults, as well as the impact of the COVID-19 pandemic on seasonal trends in RSV.

Ting Shi, PhD Released: May 19, 2022

A new vaccine candidate for prevention of RSV in older adults was added to the EMA’s PRIME scheme. Here’s my summary of the key clinical trial information.

Ting Shi, PhD Released: August 18, 2022

Learn from a leading expert about RSV in older adults, including epidemiology and reasons older adults are at increased risk compared with their younger counterparts.

Dexter James Wiseman, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: April 8, 2022 Expired: April 7, 2023

Learn from a leading expert about RSV in older adults, including epidemiology and reasons older adults are at increased risk compared with their younger counterparts.

Dexter James Wiseman, MD Released: April 8, 2022

Learn from a leading expert about strategies for overcoming difficulties related to the diagnosis and impact of RSV in older adults.

Dexter James Wiseman, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: April 13, 2022 Expired: April 12, 2023

Learn from a leading expert about strategies for overcoming difficulties related to the diagnosis and impact of RSV in older adults.

Dexter James Wiseman, MD Released: April 13, 2022

Learn from a leading expert about RSV immunology and the current status of the most promising vaccines in development for older adults.

Dexter James Wiseman, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: April 6, 2022 Expired: April 5, 2023

Learn from a leading expert about RSV immunology and the current status of the most promising vaccines in development for older adults.

Dexter James Wiseman, MD Released: April 6, 2022

Learn from a leading expert about RSV in older adults, including epidemiology, risk for severe outcomes, identification, and vaccines in development.

Dexter James Wiseman, MD Released: August 29, 2022

RSV is not just a childhood illness. Learn from a leading expert about RSV in older adults, including epidemiology and reasons older adults are at increased risk compared with their younger counterparts.

Dexter James Wiseman, MD Released: May 5, 2022

Learn from a leading expert about strategies for overcoming difficulties related to the diagnosis and impact of RSV in older adults.

Dexter James Wiseman, MD Released: May 5, 2022

Learn from a leading expert about RSV immunology, the economic burden of RSV, and the current status of the most promising vaccines in development for older adults.

Dexter James Wiseman, MD Released: May 5, 2022